| 000 | 01671 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515160722.0 | ||
| 264 | 0 | _c20100629 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm8000983 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGümüş, Fatma | |
| 245 | 0 | 0 |
_aSynthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMar 2009 |
||
| 300 |
_a1345-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzimidazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDNA _xchemistry |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aNucleic Acid Conformation |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aEren, Gökçen | |
| 700 | 1 | _aAçik, Leyla | |
| 700 | 1 | _aCelebi, Ayten | |
| 700 | 1 | _aOztürk, Fatma | |
| 700 | 1 | _aYilmaz, Sükran | |
| 700 | 1 | _aSagkan, Rahşan Ilikçi | |
| 700 | 1 | _aGür, Sibel | |
| 700 | 1 | _aOzkul, Aykut | |
| 700 | 1 | _aElmali, Ayhan | |
| 700 | 1 | _aElerman, Yalçin | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 52 _gno. 5 _gp. 1345-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm8000983 _zAvailable from publisher's website |
| 999 |
_c18663132 _d18663132 |
||